Note: average (larger bar) and median are shown

Slides:

Advertisements

Similar presentations

State of the Art The Status and Trends of HIV/AIDS Epidemics

Advertisements

Estimating incidence of heroin use from treatment data presentation for TDI expert meeting Lucas Wiessing (EMCDDA), Lucilla Ravà and Carla Rossi (Univ.

Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups funded by the European Commissions Directorate General for Health.

National Institute for Public Health and the Environment HIV, HCV, and HBV in injecting drug users in Europe Mirjam Kretzschmar Centre for Infectious Disease.

Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.

Hepatitis A Last updated August Hepatitis A virus Associated with poor hygiene and sanitation - primarily transmitted from person-to-person via.

Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.

Hepatitis C In Alaska’s Department of Corrections

Epidemiology of hepatitis B in Ireland Updated August 2014

Sex work among people who inject drugs in England, Wales & Northern Ireland: Findings from a National Survey of Health Harms and Behaviours Sara Croxford,

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

Tuberculosis in the UK 2013 report

2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.

Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.

Estimation of the Prevalence of Problem Drug Use in Lithuania Dr Gordon Hay Centre for Drug Misuse Research University of Glasgow, United Kingdom.

HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.

A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.

Annual report 2010: the state of the drugs problem in Europe.

HCV in injecting drug users: developing indicators of prevalence and responses VHPB WHO Consultation Meeting Geneva, 13 May 2002 Lucas Wiessing European.

Characteristics of new users of statins in the period 1991–2004 in the PHARMO population F.J.A. Penning-van Beest, et al. European Heart Journal 2007;28:154–159.

EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,

Predicting trends in fatal drug overdoses in Ireland: does day of the week matter? Simone Walsh, Ena Lynn and Suzi Lyons.

2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.

UNIVERSAL IMMUNIZATION OF HEPATITIS B IN ITALY Newborns of HBsAg + mothers at birth Infants of HBsAg - mothers at 3 months of age Children 12 years old.

2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.

WOMEN PROFILE AND GENDER ANALYSIS IN TREATMENT DATA UNODC DATA.

Current state of HIV and associated infections epidemic among adolescents and youth: LATVIA Anda Karnite, MPH, PHD Riga Stradins University and Baltic.

Dagmar Hedrich, Linda Montanari, Alessandra Bo, Bruno Guarita, Chloé Carpentier, Isabelle Giraudon, Luis Royuela, Lucas Wiessing « Good prison health –

Epidemiology of hepatitis B in Ireland Last updated March 2017

Esityksen nimi / Kirsi Liitsola

Epidemiology of Hepatitis A in Ireland Last updated March 2017

Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention Sharon J. Hutchinson, Sheila M.

Élise Roy, Jean-François Boudreau, Jean-François Boivin

World Tuberculosis Day 2014

HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe

Hepatitis C Incidence and Prevalence in the U.S.

A. Stepanov, A. Kruk, N. Polovinkina, A. Vinogradova

Global epidemiology of injecting drug use

Lisbon Addictions Conference — 24 October 2017

HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe

World Tuberculosis Day 2015

Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people Annual Surveillance Report 2017.

The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,

Hannah Fraser1, Natasha Martin2,1, Peter Vickerman1, Matthew Hickman1

NPS current health-related practices and challenges in responding to use and harms in Europe Findings from a multi-method study Alessandro Pirona Lisbon.

Number of HCV tests conducted

HIV/AIDS Surveillance in Europe 2011

European Centre for Disease Prevention and Control

World Tuberculosis Day 2014

Hepatitis C in the HIV-infected patient

Drug use among MSM (overview with focus on chemsex)

Virological tools to diagnose and monitor hepatitis C virus infection

Cumulative reported HIV infections per million population

HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe

An estimated 10,706 AIDS cases diagnosed in 2006 were associated with injection drug use. Approximately 84% of AIDS cases associated with injection drug.

TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C Miya John, Mayada Metwally Gastroenterology

Progress in Facilitating National HCV Prevention

Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients.

Volume 68, Issue 3, Pages (March 2018)

Volume 393, Issue 10178, Pages (March 2019)

Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation by Walter.

EMCDDA Work programme: outputs and communication

A) Annual diagnosed incidence of pulmonary embolism (PE), and b) annual full incidence of chronic thromboembolic pulmonary hypertension (CTEPH) per 100 000.

Prevalence of LTBI, hepatitis B and hepatitis C, compared with nationally representative samples. Prevalence of LTBI, hepatitis B and hepatitis C, compared.

Acute and Chronic Seizures in Patients Older Than 60 Years

Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44

Presentation transcript:

Note: average (larger bar) and median are shown Percentage of cases reporting a history of IDU among acute and chronic hepatitis C and acute hepatitis B notifications with known risk factor information, European Union 2002-06 (source EMCDDA 2008 / Wiessing et al. 2008) Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) – the need to improve quality and comparability. Euro Surveill. 2008;13(21):pii=18884. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18884 European Monitoring Centre for Drugs and Drug Addiction. 2008 Annual report: the state of the drugs problem in Europe. Lisbon: EMCDDA, 2007. http://www.emcdda.europa.eu/publications/annual-report/2008 Note: average (larger bar) and median are shown